You are here

  • Home
  • Archive
  • Volume 7, Issue 2
  • Long-term safety and effectiveness of canakinumab therapy in patients with cryopyrin-associated periodic syndrome: results from the β-Confident Registry

Citation Tools

Article menu

Download PDFPDF

XML
Autoinflammatory disorders
Original research
Long-term safety and effectiveness of canakinumab therapy in patients with cryopyrin-associated periodic syndrome: results from the β-Confident Registry

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Walker UA, Tilson HH, Hawkins PN On behalf of the CACZ885D2401 Study Investigators, et al
Long-term safety and effectiveness of canakinumab therapy in patients with cryopyrin-associated periodic syndrome: results from the β-Confident Registry
RMD Open 2021;7:e001663. doi: 10.1136/rmdopen-2021-001663